The market drew revenue of $1.9 billion in 2021, making the projected compound annual growth rate 31.6 percent through 2030. The report cites the COVID-19 pandemic as a driver of growth in mobile health applications, along with the integration of artificial intelligence into wearable technology and the rise of telemedicine. Data collection makes up over 90 percent of the digital biomarkers market, according to the July 26 report.
The report suggests that cardiac applications are another source of growth within the digital biomarkers market. North America has been the largest market for digital biomarkers technologies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
